601 related articles for article (PubMed ID: 35061214)
21. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis.
Tong J; Ji T; Liu T; Liu J; Chen Y; Li Z; Lu N; Li Q
Epilepsy Behav; 2024 Mar; 152():109653. PubMed ID: 38277848
[TBL] [Abstract][Full Text] [Related]
22. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
23. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
24. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
[TBL] [Abstract][Full Text] [Related]
25. Eslicarbazepine acetate add-on therapy for drug-resistant focal epilepsy.
Chang XC; Yuan H; Wang Y; Xu HQ; Hong WK; Zheng RY
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD008907. PubMed ID: 34155624
[TBL] [Abstract][Full Text] [Related]
26. Effect of lifetime antiepileptic drug treatment history on efficacy and tolerability of adjunctive brivaracetam in adults with focal seizures: Post-hoc analysis of a randomized, placebo-controlled trial.
Klein P; McLachlan R; Foris K; Nondonfaz X; Elmoufti S; Dimova S; Brandt C
Epilepsy Res; 2020 Nov; 167():106369. PubMed ID: 32717713
[TBL] [Abstract][Full Text] [Related]
27. Conversion to brivaracetam monotherapy for the treatment of patients with focal seizures: Two double-blind, randomized, multicenter, historical control, Phase III studies.
Arnold S; Badalamenti V; Diaz A; Gasalla T; McShea C; Whitesides J; Fakhoury T
Epilepsy Res; 2018 Mar; 141():73-82. PubMed ID: 29486396
[TBL] [Abstract][Full Text] [Related]
28. Long-term safety and efficacy of brivaracetam in adults with focal seizures: Results from an open-label, multinational, follow-up trial.
Arnold S; Laloyaux C; Schulz AL; Elmoufti S; Yates S; Fakhoury T
Epilepsy Res; 2020 Oct; 166():106404. PubMed ID: 32731118
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
Rosenfeld WE; Nisman A; Ferrari L
Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
[TBL] [Abstract][Full Text] [Related]
30. Long-term efficacy and tolerability of adjunctive brivaracetam in adults with focal to bilateral tonic-clonic (secondary generalized) seizures: Post hoc pooled analysis.
Moseley BD; Dimova S; Elmoufti S; Laloyaux C; Asadi-Pooya AA
Epilepsy Res; 2021 Oct; 176():106694. PubMed ID: 34218211
[TBL] [Abstract][Full Text] [Related]
31. Time to baseline seizure count in patients with focal seizures receiving adjunctive eslicarbazepine acetate in a phase IV clinical trial.
Aboumatar S; Krishnaiengar SR; Cantu D; Zhang Y; Grinnell T
Clin Neurol Neurosurg; 2023 Feb; 225():107552. PubMed ID: 36657359
[TBL] [Abstract][Full Text] [Related]
32. Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASD.
Mehta D; Davis M; Epstein AJ; Wensel B; Grinnell T; Thach A; Williams GR
J Med Econ; 2021; 24(1):939-948. PubMed ID: 34311671
[TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.
Klein P; Schiemann J; Sperling MR; Whitesides J; Liang W; Stalvey T; Brandt C; Kwan P
Epilepsia; 2015 Dec; 56(12):1890-8. PubMed ID: 26471380
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of adjunctive cenobamate based on patient etiology: Post-hoc analysis of YKP3089C017 randomized clinical trial.
Xu J; Wei W; Liu Y; Ye H; Liu X
Seizure; 2024 May; 118():95-102. PubMed ID: 38652999
[TBL] [Abstract][Full Text] [Related]
35. Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis.
Benbadis S; Klein P; Schiemann J; Diaz A; Elmoufti S; Whitesides J
Epilepsy Behav; 2018 Mar; 80():129-134. PubMed ID: 29414542
[TBL] [Abstract][Full Text] [Related]
36. New evidence in adjunctive treatment of focal-onset seizures in adults: a critical appraisal.
Lattanzi S
Glob Reg Health Technol Assess; 2022; 9(Suppl 2):14-19. PubMed ID: 36628128
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.
Van Paesschen W; Hirsch E; Johnson M; Falter U; von Rosenstiel P
Epilepsia; 2013 Jan; 54(1):89-97. PubMed ID: 22813235
[TBL] [Abstract][Full Text] [Related]
38. Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.
Sperling MR; Abou-Khalil B; Harvey J; Rogin JB; Biraben A; Galimberti CA; Kowacs PA; Hong SB; Cheng H; Blum D; Nunes T; Soares-da-Silva P;
Epilepsia; 2015 Feb; 56(2):244-53. PubMed ID: 25528898
[TBL] [Abstract][Full Text] [Related]
39. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies.
Moseley BD; Sperling MR; Asadi-Pooya AA; Diaz A; Elmouft S; Schiemann J; Whitesides J
Epilepsy Res; 2016 Nov; 127():179-185. PubMed ID: 27608437
[TBL] [Abstract][Full Text] [Related]
40. Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies.
Elger C; Koepp M; Trinka E; Villanueva V; Chaves J; Ben-Menachen E; Kowacs PA; Gil-Nagel A; Moreira J; Gama H; Rocha JF; Soares-da-Silva P
CNS Neurosci Ther; 2017 Dec; 23(12):961-972. PubMed ID: 29030894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
